Library Subscription: Guest
International Journal of Medicinal Mushrooms

Published 12 issues per year

ISSN Print: 1521-9437

ISSN Online: 1940-4344

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) IF: 1.2 To calculate the five year Impact Factor, citations are counted in 2017 to the previous five years and divided by the source items published in the previous five years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) 5-Year IF: 1.4 The Immediacy Index is the average number of times an article is cited in the year it is published. The journal Immediacy Index indicates how quickly articles in a journal are cited. Immediacy Index: 0.3 The Eigenfactor score, developed by Jevin West and Carl Bergstrom at the University of Washington, is a rating of the total importance of a scientific journal. Journals are rated according to the number of incoming citations, with citations from highly ranked journals weighted to make a larger contribution to the eigenfactor than those from poorly ranked journals. Eigenfactor: 0.00066 The Journal Citation Indicator (JCI) is a single measurement of the field-normalized citation impact of journals in the Web of Science Core Collection across disciplines. The key words here are that the metric is normalized and cross-disciplinary. JCI: 0.34 SJR: 0.274 SNIP: 0.41 CiteScore™:: 2.8 H-Index: 37

Indexed in

Studies on the Triterpenoid Constituents of the Spores of Ganoderma lucidum (Curt.: Fr.) P. Karst. (Aphyllophoromycetideae)

Volume 1, Issue 2, 1999, pp. 147-152
DOI: 10.1615/IntJMedMushrooms.v1.i2.40
Get accessGet access

ABSTRACT

Five compounds were isolated from the ether-soluble fraction of the spores of Ganoderma lucidum (Curt.: Fr.) P. Karst. On the basis of their chemical properties and spectral data (MS, UV, IR, 1H, and 13C-NMR), they were identified as 3,7,11,12,15,23-hexaoxo-5α-lanosta-8-en-26-oic acid (I); ganoderic acids B (II), C (III), and E (IV); and ganodermanontriol (V). Compound I is a new natural product named ganosporeric acid A. Compounds II, III, IV, and V are known compounds and were obtained for the first time from the spores of G. lucidum. Pharmacological experiments showed that ganosporeric acid A has GPT-lowering activity in mice with liver injury caused by CCI4 and GaNI and exhibits hepaoprotective effects.

CITED BY
  1. Paterson R. Russell M., Ganoderma – A therapeutic fungal biofactory, Phytochemistry, 67, 18, 2006. Crossref

  2. Müller Claudia I., Kumagai Takashi, O’Kelly James, Seeram Navindra P., Heber David, Koeffler H. Phillip, Ganoderma lucidum causes apoptosis in leukemia, lymphoma and multiple myeloma cells, Leukemia Research, 30, 7, 2006. Crossref

  3. Zhang Hui, Li Wen-Juan, Nie Shao-Ping, Chen Yi, Wang Yuan-Xing, Xie Ming-Yong, Structural characterisation of a novel bioactive polysaccharide from Ganoderma atrum, Carbohydrate Polymers, 88, 3, 2012. Crossref

  4. Alambin F., Motamed Fath P., Ebrahimi Hosseinzadeh B., Hatamian Zarmi A., Sahraeian R., Yazdian F., Leukemia stem cells, direct targeting of CD123 based on the nano-smart polymer PMBN, RSC Advances, 6, 98, 2016. Crossref

Begell Digital Portal Begell Digital Library eBooks Journals References & Proceedings Research Collections Prices and Subscription Policies Begell House Contact Us Language English 中文 Русский Português German French Spain